Shuo‐Wang Qiao

University of Oslo, Oslo University Hospital

Papers

Total Citations

383

H-Index

About

Shuo-Wang Qiao is a leading immunologist whose work has fundamentally shaped our understanding of celiac disease pathogenesis. Her research centers on the molecular interplay between tissue transglutaminase (TG2) and dietary gliadin peptides, revealing how this interaction drives the autoimmune response. In her landmark 2002 study, cited over 230 times, Qiao demonstrated that TG2 selectively deamidates specific glutamine residues in gliadin, creating high-affinity epitopes recognized by disease-causing T cells. This seminal discovery explained why only certain gluten peptides trigger inflammation in celiac patients. She further advanced the field in her 2004 work, cited more than 150 times, by characterizing the covalent complexes formed between TG2 and gliadin. This research elucidated the dual role of TG2—both as the target of autoantibodies and as the enzyme that generates immunogenic peptides. Qiao’s contributions have provided the molecular basis for understanding T cell selection in celiac disease, directly informing the development of novel therapeutic strategies, including gluten detoxification and immune-modulatory approaches. Her work remains essential reading for researchers exploring autoimmunity, mucosal immunology, and antigen presentation.